• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2300097 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2023-05-25 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2400202 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2024-09-04 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2101011 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2021-04-19 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSZ2300028 司库奇尤单抗注射液 secukinumab Injection Biological Products License Renew 2023-06-28 Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JXSS2500054 司库奇尤单抗注射液 secukinumab Injection Biological Products(3.1) Import Drug Application 2025-05-12 Beijing Novartis Pharma Co Ltd;Novartis Pharmaceutical Manufacturing GmbH;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2200202 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2022-10-18 Sandoz GmbH;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2101116 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2021-08-31 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2400073 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2024-04-03 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2300099 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2023-05-25 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2400159 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2024-07-17 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2101219 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2021-12-31 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
CXSS2500024 司库奇尤单抗注射液 secukinumab Injection Biological Products(3.3) New Drug Application 2025-02-08 Bio-Thera Solutions Ltd view
JYSB2200049 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2022-03-17 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSZ2300026 司库奇尤单抗注射液 secukinumab Injection Biological Products License Renew 2023-06-28 Beijing Novartis Pharma Co Ltd;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2101195 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2021-12-20 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2400072 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2024-04-03 Novartis Pharmaceutical Manufacturing GmbH;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2300098 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2023-05-25 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JYSB2400161 司库奇尤单抗注射液 secukinumab Injection Biological Products Supplementary Application 2024-07-17 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JXSL2101119 司库奇尤单抗注射液 secukinumab Injection Biological Products(2.2) Import Drug Application 2021-10-22 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG view
CXSS2500023 司库奇尤单抗注射液 secukinumab Injection Biological Products(3.3) New Drug Application 2025-02-08 Bio-Thera Solutions Ltd view